Left Ventricular (LV) Pacing During TAVR: Learning from the Experience in the EU
Date
Wednesday, November 19, 2025
Wednesday, November 19, 2025
Time
7:00 PM (UTC-05:00) Eastern Time (US & Canada)
7:00 PM (UTC-05:00) Eastern Time (US & Canada)
Duration
60 minutes
60 minutes
Credit Type
CME, CNE, AANP, AAPA, CCI
CME, CNE, AANP, AAPA, CCI
Intended Learners
This activity is designed for Interventional Cardiologists, Cardiac Electrophysiologists, Cardiac Surgeons, Nurses, Techs and all Cath Lab Staff.
Learning Objectives
- Define left ventricular (LV) pacing and describe how it differs from conventional right ventricular pacing during TAVR.
- Explain the rationale for LV pacing during TAVR, including physiological benefits and potential impact on hemodynamic stability.
- Interpret available European clinical and safety data on LV pacing in TAVR, including procedural outcomes, complication rates, and patient populations studied.
- Apply practical implications for clinical practice, including patient selection, procedural workflow, and device management when incorporating LV pacing.
Continuing Education
|
|
Supported by an independent educational grant from Haemonetics
Speakers

James Harvey, MD, MSc, FACC, FSCAI
Interventional Cardiologist, Vice President & Chief Medical Officer
Heart and Vascular Service Line, WellSpan Health System
Interventional Cardiologist, Vice President & Chief Medical Officer
Heart and Vascular Service Line, WellSpan Health System

Ander Regueiro, MD, PhD, FESC
Interventional Cardiologist
Hospital Clinic Barcelona, University of Barcelona
Interventional Cardiologist
Hospital Clinic Barcelona, University of Barcelona

Ruby Satpathy, MD, FACC, FSCAI
Interventional Cardiologist & Medical Director, Structural Heart Program
Baptist Health
Interventional Cardiologist & Medical Director, Structural Heart Program
Baptist Health


